Recalls / Active ingredient / Brivaracetam
Brivaracetam
1 FDA drug recall involving the active ingredient “Brivaracetam”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2021-03-15 | Class II | Briviact (brivaracetam) tablets 50 mg, 60-count bottle, Rx only Manufactured for UCB, Inc. Smyrna, GA 30080, N | Cardinal Health Inc. |